Eurofins Scientific SE

  • Market Cap: N/A
  • Industry: Miscellaneous
  • ISIN: FR0014000MR3
EUR
57.68
0.22 (0.38%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

306.42 k

Shareholding (Dec 2023)

FII

0.01%

Held by 4 FIIs

DII

99.99%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROCE of 12.82%

  • The company has been able to generate a Return on Capital Employed (avg) of 12.82% signifying low profitability per unit of total capital (equity and debt)
2

High Debt Company with a Debt to Equity ratio (avg) at times

3

With ROE of 1.75%, it has a Very Expensive valuation with a 3.51 Price to Book Value

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Miscellaneous

stock-summary
Market cap

EUR 10,813 Million ()

stock-summary
P/E

200.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

1.07%

stock-summary
Debt Equity

1.21

stock-summary
Return on Equity

1.75%

stock-summary
Price to Book

3.15

Revenue and Profits:
Net Sales:
243 Million
(Quarterly Results - Dec 2011)
Net Profit:
23 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-9.62%
0%
-9.62%
6 Months
-4.53%
0%
-4.53%
1 Year
19.62%
0%
19.62%
2 Years
5.91%
0%
5.91%
3 Years
-13.21%
0%
-13.21%
4 Years
-46.56%
0%
-46.56%
5 Years
-11.84%
0%
-11.84%

Eurofins Scientific SE for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
17.64%
EBIT Growth (5y)
19.39%
EBIT to Interest (avg)
3.53
Debt to EBITDA (avg)
3.15
Net Debt to Equity (avg)
0.82
Sales to Capital Employed (avg)
0.11
Tax Ratio
19.70%
Dividend Payout Ratio
28.14%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
12.82%
ROE (avg)
18.36%
Valuation key factors
Factor
Value
P/E Ratio
200
Industry P/E
Price to Book Value
3.51
EV to EBIT
190.82
EV to EBITDA
123.78
EV to Capital Employed
2.13
EV to Sales
19.53
PEG Ratio
1.57
Dividend Yield
0.96%
ROCE (Latest)
1.12%
ROE (Latest)
1.75%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 4 Foreign Institutions (0.01%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Eurofins Scientific SE"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 6.70% vs -2.94% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 31.74% vs -49.19% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,951.00",
          "val2": "6,514.60",
          "chgp": "6.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,417.60",
          "val2": "1,211.10",
          "chgp": "17.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "141.70",
          "val2": "118.70",
          "chgp": "19.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-10.90",
          "val2": "-15.40",
          "chgp": "29.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "405.50",
          "val2": "307.80",
          "chgp": "31.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "104.50%",
          "val2": "83.90%",
          "chgp": "2.06%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
6,951.00
6,514.60
6.70%
Operating Profit (PBDIT) excl Other Income
1,417.60
1,211.10
17.05%
Interest
141.70
118.70
19.38%
Exceptional Items
-10.90
-15.40
29.22%
Consolidate Net Profit
405.50
307.80
31.74%
Operating Profit Margin (Excl OI)
104.50%
83.90%
2.06%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 6.70% vs -2.94% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 31.74% vs -49.19% in Dec 2023

stock-summaryCompany CV
About Eurofins Scientific SE stock-summary
stock-summary
Eurofins Scientific SE
Miscellaneous
Eurofins Scientific SE is a Luxembourg-based company engaged in the business support services industry. The Company joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. It operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut Nehring GmbH in Germany, Agfirst Bay of Plenty, a fruit maturity testing laboratory in New Zealand, and Megalab SA, a clinical diagnostic laboratory in Spain. It is active through Ahma Group, Villapharma, Exova's environment testing laboratories in Eastern Canada, ASL analises ambientais in Brazil, MVZ fur Laboratoriumsmedizin am Hygiene-Institut Gmbh, Alphora Research, Genoma Laboratory Group, Ana Laboratories Inc, Lifecodexx AG, Gatc Biotech AG, Japan Analytical Chemistry Consultants Co. Ltd. (''Jacc''), Tsing Hua and Ecopro Research K.K. (''Ecopro'') and Craft Technologies.
Company Coordinates stock-summary
Company Details
23 val Fleuri , LUXEMBOURG None : 1526
Registrar Details